Trial Profile
A Phase 3, Multicenter, Open-Label Evaluation of the Safety and Tolerability of Crofelemer in HIV-Positive Subjects With Diarrhoea
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Sep 2020
Price :
$35
*
At a glance
- Drugs Crofelemer (Primary)
- Indications Diarrhoea
- Focus Adverse reactions; Registrational
- Sponsors Salix Pharmaceuticals
- 02 Apr 2014 New trial record
- 23 Apr 2013
- 31 Oct 2011